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ABSTRACT
Cardiopulmonary bypass (CPB) allows operations on the heart 
in a motionless and bloodless field while reducing cardiac 
workload and sustaining systemic and coronary perfusion. 
Failure to wean from CPB remains a significant problem. 
Results from recent large registry data have shown dramatic 
improvement in the survival following ventricular assistance 
for post cardiotomy failure if instituted early. We show how 
post-cardiotomy heart failure can be successfully treated by 
proactive use of biventricular assist devices (BIVAD).
INTRODUCTION
Cardiopulmonary  bypass  (CPB)  allows  operations  on  the 
heart  in  a  motionless  and  bloodless  field  while  reducing 
cardiac  workload  and  sustaining  systemic  and  coronary 
perfusion. It has gained widespread acceptance but failure 
to wean from CPB remains a significant problem. Factors 
determining post-cardiotomy failure include: perioperative 
ischaemia, complications of PCI, patients presenting with 
acute  coronary  syndrome,  post-infarct  VSD,  inadequate 
myocardial  protection,  diffuse  non-graftable  disease,  or 
complications  associated  with  a  chronically  pressure  and 
volume overloaded ventricle. This can result in a significant 
amount of hibernating and stunned myocardium. 
Post-cardiotomy heart failure can be reversible but carries 
a high risk of mortality. The initial four decades after the 
advent of cardiac surgery witnessed a gradual decrease in the 
incidence of post-cardiotomy failure as a result of improved 
peri-operative  care  and  better  myocardial  preservation 
strategies,  however,  in  the  last  decade  the  incidence  has 
gradually started to rise as the case mix for cardiac surgery 
has become increasingly complex1. We have seen a dramatic 
change in the referral pattern of patients being offered cardiac 
surgery; many have high risk profiles that would have been 
denied intervention a decade or two ago. 
We present a case of post-cardiotomy failure in a patient with 
unstable angina with rest pain being treated by biventricular 
assist devices (BIVAD). This is the first adult case to survive 
with BIVAD use following cardiac surgery in the province.
CASE
A  67-year-old  man  was  admitted  to  the  Department  of 
Cardiac  Surgery  for  urgent  CABG.  Three  weeks  earlier, 
he  was  admitted  to  the  Coronary  Care  Unit  (CCU)  with 
unstable angina and a Non-ST segment myocardial infarction. 
Angiography revealed triple vessel disease and impaired left 
ventricular function (Ejection fraction 18%). His operation 
was deferred on initial admission due to MRSA grown from 
the right groin and he continued to experience chest pain 
on minimal exertion daily, with activity limited to bedside 
movements only. 
In theatre soon after intubation, he experienced an asystolic 
arrest and a rapid median sternotomy was performed with 
CPB. Antegrade cold blood cardioplegia was instituted to 
arrest and protect the heart and systemic hypothermia to 28°C 
was used. The left long saphenous vein was used to bypass the 
Left anterior descending artery (LAD), obtuse marginal artery 
(OM) and the posterior descending artery (PDA). The patient 
was re-warmed and an attempt was made to wean off CPB. 
This was unsuccessful as the heart was barely able to maintain 
a systolic blood pressure of 60mmHg, with CVP of 20mmHg 
and wedge pressure 20mmHg despite adequate preload, high 
inotropic and intra aortic balloon pump (IABP) support. A 
second attempt was made after giving the heart 20mins on 
Fig 1. Photograph depicting the close up of a Biomedicus 
(Medtronic Inc) pump with the inlet and outlet connectors. Two 
pumps were used, one for the right ventricular bypass and one for 
the left ventricular bypass.© The Ulster Medical Society, 2008.
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bypass to recover but the left ventricle struggled and the right 
ventricle showed signs of dilatation and dysfunction. The 
clinical scenario suggested bi-ventricular failure. 
A decision was made to support both ventricles by establishing 
temporary left and right heart bypass using two Biomedicus 
(Medtronic Inc; Minneapolis) pumps as Biventricular assist 
devices (BIVAD). Right heart bypass was achieved by the 
right atrial two-stage cannula for venous drainage and a 24 
French aortic cannula (pulmonary artery cannula) placed in 
the right ventricular outflow tract and advanced in the main 
pulmonary artery for return. Left heart bypass was achieved 
by inserting a 38 French angled anvil cannula (left atrial 
cannula) through a purse string suture in the right superior 
pulmonary vein and the inflow cannula was the aortic 24 
French  cannula  initially  used  for  CPB  (Fig.  1).  With  all 
cannulae in place and secured, heart assist was established and 
acceptable flow rates in the region of 2.2 lt/min/m2 achieved 
(Figs.  2  and  3). All  catecholamines  except  a  continuous 
infusion  of  nor-epinephrine,  milrinone  and  inhaled  nitric 
oxide were discontinued, the patients’ acidosis and lactate 
levels normalised with 8 hours of BIVAD support. 
The patient developed a coagulopathy due in part to rapid 
heparinisation and prolonged CPB and required substantial 
infusions of coagulation products. The chest was left open and 
packed with sterile gauze and he had repeated re-explorations 
over the next 24 hours to identify and correct surgical bleeding 
points as they became apparent. 
After 48 hours an improvement in ventricular function was 
observed on trial of weaning, so BIVAD support was weaned 
off and removed. The sternum was left open with the skin 
closed to allow rapid re-exploration if required. By day 4 
the  sternotomy  could  be  closed  without  haemodynamic 
compromise and on day 5, IABP was removed. He made 
steady  improvement  and  was  extubated  on  day  11  with 
a  minitracheostomy  tube  placed  to  aid  aspiration  of 
bronchial secretions. He was discharged home on day 43. 
On review at six weeks, cardiac and respiratory parameters, 
were  satisfactory  but  an  abdominal  mass  was  palpated. 
He underwent resection for a localised ileal stricture and 
anastomoses four months from his initial cardiac surgical 
procedure. At last follow-up he was pain-free and able to 
walk 2 miles daily. 
DISCUSSION 
This  case  demonstrates  a  not  too  infrequent  scenario  of 
a  significantly  stunned  myocardium  in  spite  of  adequate 
myocardial  revascularisation  in  a  patient  with  ongoing 
ischaemia  peri-operatively.  Currently  about  6%  of 
patients  develop  post-cardiotomy  ventricular  failure. 
Phosphodiesterase inhibitors, catecholamines and intra-aortic 
balloon pump (IABP) are frequently employed for treating 
post-cardiotomy failure and are successful in the majority 
of  patients.  However,  1%  of  patients  undergoing  cardiac 
surgery develop intractable ventricular failure, which is non-
responsive to catecholamine and IABP therapy1. Traditionally, 
ventricular assist devices were reserved as a last resort for 
these types of patients, due to earlier experience of mortality 
in excess of 75% with the use of assist devices2,3. 
The  Biomedicus  pump  (Medtronic  Inc)  used  consists  of 
valveless  rotator  cones  that  impart  a  circular  motion  to 
incoming  blood  by  viscous  drag  and  constrained  vortex 
principles  generating  pressure  and  flow. This  assembly  is 
housed in a polycarbonate cone shaped container with inlet 
and  outlet.  These  pumps  are  afterload  dependent  unlike 
the roller type pump. They can be used to bypass both the 
Fig 2. Photograph of the console of the Biomedicus pump 
(Medtronic Inc), two independent consoles controlled the 
Biomedicus pumps for flow and revolutions per minute.
Fig 3. Illustration depicting the insertion of the cannulas for 
BIVAD.© The Ulster Medical Society, 2008.
38 The Ulster Medical Journal
www.ums.ac.uk
right and left ventricle, are widely available and are easy 
to operate. They are driven by a magnetic impeller that has 
no direct contact with the blood within. A separate console 
allows the operator to control the revolutions and set alarms. 
Conventional bypass cannulas are used together with bypass 
tubing  to  connect  the  ventricle  to  the  pump  outside  the 
body.
A recent comprehensive review of contemporary practice 
reveals a dramatic improvement in survival following use of 
ventricular assist devices in patients needing post cardiotomy 
support in several North American centres4. This is mainly 
attributed  to  earlier  recognition  and  use  of  assist  devices 
prior to irreversible ventricular failure, improving the overall 
survival to discharge by ~50%. Early implantation of an assist 
device capable of supporting adequate flow and allowing the 
heart to rest may improve results and allow recovery of the 
stunned myocardium1-4. There is an argument for pro-active 
use  of  ventricular  assist  devices  early,  to  gain  maximum 
advantage by allowing the ventricle to recover.
The use of ventricular assist devices is not without technical 
problems and complications. The Randomized Evaluation of 
Mechanical Assistance for the Treatment of Congestive Heart 
Failure (REMATCH) trial was designed to compare the results 
of mechanical assistance versus the medical management for 
patients suffering from heart failure5. This trial results show 
device infection was 28%; bleeding events were 42%, and 
device malfunction 35%. This must be balanced with the 
overwhelming survival benefit of mechanical support. In the 
LVAD group, the corresponding survival rates were 48% at 
12 months and 23% at 24 months, representing a relative risk 
reduction of death of 48% over the two-year period5. 
Similar  randomised  data  is  lacking  in  post-cardiotomy 
failure, due to the ethical issues involved in randomising such 
patients, but; there is ample data from bridge to recovery and 
bridge to transplant ventricular assist therapy in the context 
of post-cardiotomy failure1,4. 
The centrifugal pumps used in this case are easily available 
in most units without dedicated heart failure facilities and 
are easy to use and maintain. As the patient profiles accepted 
for coronary revascularisation are undergoing rapid changes 
towards performing revascularisation procedures in a high-
risk population; the use of such devices pro-actively to help 
the myocardium recover is prudent. Patients can recover to 
lead a normal life after postcardiotomy heart failure if VAD 
therapy is instituted early.
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